EBA-175 RII-NG Malaria Vaccine Administered Intramuscularly in Semi-immune Adults

Clinical trial NCT01026246 · COMPLETED

Trial details

NCT number

NCT01026246

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Status

COMPLETED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2010-06-01

Primary completion

2012-03-01

Enrollment

60

View on ClinicalTrials.gov